AGLE Market Cap History



Below is a table of the AGLE market cap history going back to 4/7/2016:

Date AGLE Market Cap
4/7/2016111.67M
5/19/201698.71M
8/8/201661.69M
11/8/201680.18M
3/23/201798.47M
5/8/201786.50M
8/7/201754.46M
11/3/201782.06M
3/8/2018147.94M
5/4/2018213.12M
8/3/2018196.42M
11/2/2018222.13M
3/1/2019247.56M
5/1/2019192.13M
8/1/2019259.97M
8/2/2019294.23M
11/1/2019238.84M
2/20/2020234.72M
5/1/2020334.45M
8/5/2020309.52M
11/2/2020354.73M
3/12/2021381.73M
5/5/2021360.32M
7/30/2021300.77M
10/28/2021365.95M
2/24/2022141.67M
4/28/202278.65M
7/29/202225.39M
10/28/202256.59M
2/21/202329.75M
5/2/202310.99M
8/4/202348.57M
11/3/202345.79M

Also see: AGLE Shares Outstanding History
and AGLE YTD Return
AGLE Historical Market Cap:
-11.10% CAGR
AGLE Historical Market Cap: +-11.10% CAGR

Mouse over chart for data details
4/7/2016 ...11/3/2023
Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels. We show 33 historical shares outstanding datapoints in our AGLE shares outstanding history coverage, used to compute AGLE market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AGLE market cap history over the course of time is important for investors interested in comparing AGLE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AGLE versus a peer is one thing; comparing AGLE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AGLE can fluctuate over the course of history. With this page we aim to empower investors researching AGLE by allowing them to research the AGLE market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AGLE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aeglea BioTherapeutics (AGLE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AGN Market Cap History
AGRX Market Cap History
AGTC Market Cap History
AGTI Market Cap History
AHCO Market Cap History
AHPI Market Cap History
AIKI Market Cap History
AIMD Market Cap History
AIMT Market Cap History
AIPT Market Cap History
More Healthcare companies »

 

AGLE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.